Diabetes

>

Latest News

 Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care / image credit ©yurii/stock.adobe.com
Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care

December 15th 2025

CGM users experienced fewer ED and inpatient days and better glycemic outcomes, but most eligible adults in this large cohort did not use the technology.

ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management / image credit Rita R Kalyani, MD, MHS   Courtesy of the American Diabetes Assocation
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management

December 9th 2025

FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option / image credit ©Tada Images/stock.adobe.com
FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option

December 4th 2025

Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity / image courtesy of Courtesy of Peking University Health Science Center
Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity

November 20th 2025

FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes / Image credit: ©Araki Ilustrations/AdobeStock
FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes

November 19th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.